Skip to main content
. 2016 Jul 28;9(9):8311–8325. doi: 10.18632/oncotarget.10882

Table 3. Association between the cumulative effect of 5 independent SNPs and glioma risk in dataset2.

Risk prediction models Cases (%) Controls (%) OR(95%CI) P value Trend P value
743 900
counts Genetic Risk Score (cGRS)
      0-1 24(3.23) 54(6.00) 1.00(reference)
      2 77(10.36) 142(15.78) 1.22(0.70-2.13) 0.482
      3 146(19.65) 275(30.56) 1.20(0.71-2.01) 0.504
      4 220(29.61) 215(23.89) 2.30(1.37-3.86) 0.002
      5 166(22.34) 135(15.00) 2.77(1.63-4.71) 1.76E-04
      ≥6 110(14.80) 79(8.78) 3.13(1.79-5.49) 6.62E-05 2.73E-12
weighed Genetic Risk Score (wGRS)1
      0(<Q25) 120(16.15) 259( 28.78) 1.00(reference)
      1(Q25∼Q50) 107(14.40) 198(22.00) 1.17(0.85-1.61) 0.345
      2(Q50∼Q75) 229(30.82) 219(24.33) 2.26(1.70-3.00) 2.14E-08
      3(≥Q75) 287(38.63) 224(24.89) 2.77(2.10-3.65) 7.67E-13 3.63E-15
weighed Genetic Risk Score (wGRS)2
      0(<Q25) 120(16.15) 259(28.78) 1.00(reference)
      1(Q25∼Q50) 107(14.40) 199(22.11) 1.16(0.84-1.60) 0.361
      2(Q50∼Q75) 226(30.42) 219(24.33) 2.24(1.68-2.98) 3.12E-08
      3(≥Q75) 287(39.03) 223(24.78) 2.78(2.10-3.70) 6.25E-13 3.13E-15